PROTALIX BIOTHERAPEUTICS, INC. (PLX)

[Spideyboy]

That was my question.

They have definitely lined up the cash to get PRX-102 to the finish line, as they have mentioned on a number of occasions that they are already fully funded into 2020, which would be after the Phase III read-outs, which would trigger other milestone payments, and which also doesn't take into account any potential partnership on OPRX-106 and funds that come with that, nor does it take into account the same for 110, though I would expect OPRX-106 to take precedence.

My only thinking is that this may be a precautionary measure with regards continuing the further clinical development on 106 or 110 if partnering discussions are felt to take too much time. I would again hope this to be simply a precautionary measure and taking the foresight of taking all possible eventualities into account, however as such one should plan for all eventualities.

However I was hoping someone else might offer a different perspective first.

Perhaps my question on this was too far down my post for most people to notice, so thanks for your follow-up! :)